Stock comparison
Lam Research
NICE
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LRCX
Lam Research
Market cap
$381.86B
Sector
Technology
NICE
NICE
Market cap
$5.52B
Sector
Technology
Overall winner
Lam Research LRCX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LRCX | NICE | Winner |
|---|---|---|---|
| Warren Buffett | 78B | 57C | LRCX |
| Benjamin Graham | 88A | 40D | LRCX |
| Philip Fisher | 76B | 64C | LRCX |
| Peter Lynch | 69B | 52C | LRCX |
| Joel Greenblatt | 84C | 30F | LRCX |
| Charlie Munger | 86A | 44D | LRCX |
| Terry Smith | 88A | 48D | LRCX |
Side-by-side metrics
| Metric | LRCX | NICE |
|---|---|---|
| Market cap | $381.86B | $5.52B |
| P/E (TTM) | 55.4x | 9.9x |
| EV/EBIT | 62.9x | 7.7x |
| ROIC (TTM) | 42.79% | 12.21% |
| Gross margin | 49.98% | 65.79% |
| Net margin | 30.94% | 17.59% |
| Revenue CAGR 5y | 5.96% | 11.27% |
| EPS CAGR 5y | 11.27% | 32.88% |
| Debt / Equity | 0.4x | 0.0x |
| Dividend yield | 0.34% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LRCX leads on
- Dividend yield0.34%vs 0.0%+100%
- Market cap$381.86Bvs $5.52B+99%
- ROIC (TTM)42.79%vs 12.21%+71%
- Net margin30.94%vs 17.59%+43%
NICE leads on
- Debt / Equity0.0xvs 0.4x+93%
- EV/EBIT7.7xvs 62.9x+88%
- P/E (TTM)9.9xvs 55.4x+82%
- EPS CAGR 5y32.88%vs 11.27%+66%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.